Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.63 |
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA9 | Q16790 | 3/20 | 0.63 |
| ▸ | AGXT | P21549 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6859827 | 1.00 | CA2 (0.63) | CA2CA1CA9AGXTGAA | |
| SCHEMBL7890851 | 0.93 | CA2 (0.56) | CA2CA1CA9AGXTGAA | |
| SCHEMBL5870520 | 0.93 | CA2 (0.56) | CA2CA1CA9AGXTGAA | |
| SCHEMBL5697490 | 0.91 | GAA (0.55) | CA2CA1CA9GAAALDH1A1 | |
| SCHEMBL776679 | 0.91 | CA1 (0.54) | CA2CA1CA9GAAALDH1A1 | |
| SCHEMBL14266859 | 0.91 | CA2 (0.54) | CA2CA1CA9AGXTGAA | |
| SCHEMBL5050170 | 0.91 | CA2 (0.54) | CA2CA1CA9AGXTGAA | |
| SCHEMBL19067740 | 0.91 | CA2 (0.54) | CA2CA1CA9AGXTGAA | |
| SCHEMBL7909564 | 0.91 | CA2 (0.54) | CA2CA1CA9AGXTALDH1A1 | |
| SCHEMBL2890 | 0.91 | CA9 (0.53) | CA2CA1CA9GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851529-B2 | Triazine ring-containing polymer, and thermoplastic article and optical part including same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-12-26 | — | — | US | disclosed |
| US-20200362112-A1 | TRIAZINE RING-CONTAINING POLYMER, AND THERMOPLASTIC ARTICLE AND OPTICAL PART INCLUDING SAME | NATIONAL UNIVERSITY CORPORATION IWATE UNIVERSITY (JP) | 2020-11-19 | — | — | US | disclosed |
| US-9642360-B2 | Antimicrobial polymers formed by bulk polyaddition | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-05-09 | — | — | US | disclosed |
| US-20170094964-A1 | ANTIMICROBIAL POLYMERS FORMED BY BULK POLYADDITION | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-04-06 | — | — | US | disclosed |
| US-6013407-A | PHOTORESISTS WITH PHENOLIC RESINS, QUINONEDIAZIDE SULFONATES, PHOTOSENSITIVE AGENTS AND PHENOLIC COMPOUNDS | NIPPON ZEON CO., LTD. (JP) | 2000-01-11 | — | — | US | disclosed |
| EP-0831370-A1 | POSITIVE RESIST COMPOSITION | NIPPON ZEON CO., LTD. (JP) | 1998-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170094964-A1 | ANTIMICROBIAL POLYMERS FORMED BY BULK POLYADDITION | PARG, PARN, PUF60 | CA2 3437/4885CA1 4431/4885CA9 3375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.